Events
Prescription Drug Enforcement: Avoiding an Rx for Disaster
Roundtable panelists:
- Eileen Dinnan, Supervisory Special Agent, U.S. Drug Enforcement Administration, Tactical Diversion Squad
- John Gadea, Director, Drug Control Division, Department of Consumer Protection
- Leonard Levin, Supervisory Diversion Investigator, U.S. Drug Enforcement Administration
- Margery Feinzig, Partner, Wiggin and Dana LLP
Program moderator:
- James Glasser, Partner and Chair of the Litigation Department, Wiggin and Dana LLP
Topics to be discussed:
Federal and state enforcement authorities have ramped up enforcement efforts to stem the rising tide of illegal use, prescription and diversion of controlled substances. At this year's Roundtable, we will discuss:
- Federal Drug Enforcement Administration (DEA) and Connecticut Department of Consumer Protection's Drug Control Division (DCP) enforcement priorities and collaborations
- Connecticut's online Prescription Monitoring Program (PMP) and recent legislation requiring physician participation in the PMP
- How providers get caught up in illegal use, prescription and diversion of drugs and how to ensure compliance with federal and state requirements
- What to do if the DEA and/or DCP knock on your door.
